Underwriting Early Stage Breast Cancer: A New Approach
Robert Lund, MD

 
Trends towards diagnosing breast cancer at earlier stages and therapeutic improvements have both contributed to changes in survival patterns. It will be shown that these changes favor the use of the debit system for underwriting applicants with a history of early stage breast cancer rather than traditional temporary flat extra ratings.